Search Results - "Zyryanov, S K"

Muramyldipeptide - based compounds in current medicine: focus on glucosaminylmuramyl dipeptide by Ushkalova, E A, Zyryanov, S K, Zatolochina, K E

“…The role of immune mechanisms in the pathogenesis of almost all human diseases shown in recent decades, increase in antibiotic resistance and secondary…”
Get full text

Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma by Zyryanov, S K, Avdeev, S N, Ivanov, D A, Zhuravleva, M V, Kniajeskaia, N P, Matveev, N V, Nenasheva, N A, Fomina, D S, Frolov, M I

“…During last few years, the approaches to the management of patients with severe asthma have been revised. Monoclonal antibodies (MABs), inhibitors of…”
Get full text

The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy by Avdeev, S N, Aisanov, Z R, Belevsky, A S, Beeh, K M, Vizel, A A, Zyryanov, S K, Ignatova, G L, Kostikas, K, Leshchenko, I V, Ovcharenko, S I, Sinopal’nikov, A I, Titova, O N, Shmelev, E I

“…The main goals of COPD therapy are to achieve clinical stability with minimal clinical manifestations and low risk of relapse. The proposed COPD control…”
Get full text

Enoxaparin is a low-molecular-weight heparin with a complex chemical structure and various non-anticoagulant properties by S K Zyryanov, E A Ushkalova

“…The paper discusses the non-anticoagulant properties of unfractionated heparin and enoxaparin and their relation to their chemical structures. It is emphasized…”
Get full text

Budget impact analysis of antiplatelet therapy with ticagrelor and clopidogrel in patients with acute coronary syndrome after coronary artery bypass surgery by Zyryanov, S K, Belousov, D Yu, Afanasyeva, E V, Dumchenko, E V

“…Clinical and economic examinations were made to study whether it is appropriate to use antiplatelet therapy (APT) with ticagrelor in combination with…”
Get full text

Cost-effectiveness analysis of acalabrutinib in treatment of patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy by Zyryanov, S. K., Dyakov, I. N.

“…Objective : to conduct a clinical and economic study of acalabrutinib for the treatment of adult patients with relapsed/refractory form of mantle cell lymphoma…”
Get full text

Selection of NSAIDs for rational pharmacotherapy of chronic musculoskeletal pain: a clinical pharmacologist's perspective by Butranova, O. I., Zyryanov, S. K.

“…Chronic musculoskeletal pain (CMSP) is one of the most common pathological conditions that limits patients' physical activity and reduces their quality of…”
Get full text

Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma by Zyryanov, S. K., Orlova, K. V.

“…Objective: evaluation of the comparative pharmacoeconomic effectiveness of treatment sequences with prolgolimab as the first line and combination therapy with…”
Get full text

Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy by Zyryanov, S. K., Dyakov, I. N.

“…Objective: to evaluate the pharmacoeconomic efficiency of atezolizumab (inhibitor of programmed death ligand 1 (PD-L1)) in comparison with other checkpoint…”
Get full text

Hypromellose in Ophthalmology by Butranova, O. I., Zyryanov, S. K.

“…Dosage forms for topical ocular administration are the basis of patient management in ophthalmology. The eye is a structure evolutionarily protected from the…”
Get full text

Topical glucocorticoids in ophthalmology: a comparative analysis of efficacy and safety by Zyryanov, S. K., Butranova, O. I.

“…The symptoms of most pathological conditions in ophthalmology are based on inflammations of varying severity. Valuable tools against inflammation are topical…”
Get full text

Optimization of therapy in secondary progressive multiple sclerosis by Boyko, A. N., Zyryanov, S. K., Vlasov, Ya. V.

“…The article provides an analysis of modern methods of treatment of secondary progressive multiple sclerosis (SPMS). The only drug that has proven its…”
Get full text

Use of gabapentin for neuropathic pain therapy: A view from perspective of evidence-based medicine by Butranova, O. I., Zyryanov, S. K.

“…The aim of the study was to analyze the literature sources for pharmacodynamic and pharmacokinetic features of gabapentin, providing its use in patients with…”
Get full text

New opportunities for lowering low-density lipoprotein cholesterol: comparative characteristics of PCSK9-targeted therapy by Zyryanov, S. K., Butranova, O. I.

“…The spread of cardiovascular diseases has the nature of an epidemic, which is enhanced by lipid profile disorders, manifested by hypercholesterolemia. Numerous…”
Get full text

Microbiological monitoring of a multidisciplinary medical organization: the basis of strategic planning in the framework of the implementation of epidemiological safety by Bobrova, O. P., Fetisov, A. O., Zyryanov, S. K.

“…Relevance . Monitoring of antibiotic resistance and the frequency of isolation of microorganisms at the regional level in each medical organization is of…”
Get full text

Pharmacoeconomical analysis of the use of upadacitinib, baricitinib and dupilumab for systemic therapy of patients with moderate and severe atopic dermatitis by Zyryanov, S. K., Dyakov, I. N., Ilina, N. I.

“…Objective . Comparative pharmacoeconomic evaluation of upadacitinib, baricitinib and dupilumab for the treatment of moderate to severe atopic dermatitis…”
Get full text

The economic side of an oral sugar lowering therapy intensification by glucagon-like peptidt-1 receptor agonists by Zyryanov, S. K., Dyakov, I. N.

“…The effective control of Diabetes Mellitus (DM) is an actual problem from optimal expenditures of health care system point of view. Glucagon-like peptide-1…”
Get full text

Analysis of the infectious agent’s structure and antibiotic resistance parameters in patients in intensive care units of a multidisciplinary hospital by Butranova, O. I., Zyryanov, S. K., Gorbacheva, A. A., Putsman, G A.

“…Introduction .  Nosocomial infections are a common complication in patients treated in the intensive care unit (ICU). Microorganisms with multidrug resistance…”
Get full text

Methodological Approaches to Studying Fatal Adverse Drug Reactions by Asetskaya, I. L., Polivanov, V. A., Zyryanov, S. K.

“…Serious adverse drug reactions (ADRs) to medicinal products can cause death. It is an immediate challenge for modern medicine to prevent the possibility of…”
Get full text

Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups by Ushkalova, E. A., Zyryanov, S. K., Butranova, O. I.

“…To reduce the risk of developing adverse events (AEs) and increase the adherence of elderly patients to treatment, it is recommended to limit maximally the…”
Get full text